Product Images Divalproex Sodium
View Photos of Packaging, Labels & Appearance
Product Label Images
The following 5 images provide visual information about the product associated with Divalproex Sodium NDC 64725-0595 by Tya Pharmaceuticals, such as packaging, labeling, and the appearance of the drug itself. This resource could be helpful for medical professionals, pharmacists, and patients seeking to verify medication information and ensure they have the correct product.
Label Image - 64725 0595
This is a description of Divalproex Sodium ER 500mg tablets from Aurobindo Pharma, which has been repackaged by T.Y.A Pharmaceuticals. It comes with 80 tablets in one container and is marked with RX Only and a product code 65862-505-01. The lot number is X0 and the expiration date is not provided. The address and phone number of T.Y.A Pharmaceuticals is also included in the description. There is no additional information provided about the usage or dosage of the medication.*
Figure 1 - divalproex fig1
This is a graph showing the % reduction in CPS rate of patients taking Divalproex Sodium Delayed-Release Tablets versus a placebo. The graph shows that around 50% of patients had an improvement in CPS rate while taking Divalproex Sodium compared to the placebo group.*
Figure 2 - divalproex fig2
The text describes a graph titled "Reduction In CPS Rate" with two lines representing "High Dose Divalproex Sodium Delayed-Release Tablets" and "Low Dose Divalproex Sodium Delayed-Release Tablets". It shows the percentage of patients who experienced improvement, no change or worsening of CPS rate.*
Figure 3. Mean Reduction In 4-Week Migraine Headache Rates - divalproex fig3
Chemical Structure - divalproex str
* The product label images have been analyzed using a combination of traditional computing and machine learning techniques. It should be noted that the descriptions provided may not be entirely accurate as they are experimental in nature. Use the information in this page at your own discretion and risk.